Cargando…

PM(2.5) and cardiovascular diseases: State-of-the-Art review

Air pollution, especially exposure to particulate matter 2.5 (PM(2.5)), has been associated with an increase in morbidity and mortality around the world. Specifically, it seems that PM(2.5) promotes the development of cardiovascular risk factors such as hypertension and atherosclerosis, while being...

Descripción completa

Detalles Bibliográficos
Autores principales: Krittanawong, Chayakrit, Qadeer, Yusuf Kamran, Hayes, Richard B., Wang, Zhen, Thurston, George D., Virani, Salim, Lavie, Carl J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585625/
https://www.ncbi.nlm.nih.gov/pubmed/37869561
http://dx.doi.org/10.1016/j.ijcrp.2023.200217
_version_ 1785122992569712640
author Krittanawong, Chayakrit
Qadeer, Yusuf Kamran
Hayes, Richard B.
Wang, Zhen
Thurston, George D.
Virani, Salim
Lavie, Carl J.
author_facet Krittanawong, Chayakrit
Qadeer, Yusuf Kamran
Hayes, Richard B.
Wang, Zhen
Thurston, George D.
Virani, Salim
Lavie, Carl J.
author_sort Krittanawong, Chayakrit
collection PubMed
description Air pollution, especially exposure to particulate matter 2.5 (PM(2.5)), has been associated with an increase in morbidity and mortality around the world. Specifically, it seems that PM(2.5) promotes the development of cardiovascular risk factors such as hypertension and atherosclerosis, while being associated with an increased risk of cardiovascular diseases, including myocardial infarction (MI), stroke, heart failure, and arrhythmias. In this review, we seek to elucidate the pathophysiological mechanisms by which exposure to PM(2.5) can result in adverse cardiovascular outcomes, in addition to understanding the link between exposure to PM(2.5) and cardiovascular events. It is hypothesized that PM(2.5) functions via 3 mechanisms: increased oxidative stress, activation of the inflammatory pathway of the immune system, and stimulation of the autonomic nervous system which ultimately promote endothelial dysfunction, atherosclerosis, and systemic inflammation that can thus lead to cardiovascular events. It is important to note that the various cardiovascular associations of PM(2.5) differ regarding the duration of exposure (short vs long) to PM(2.5), the source of PM(2.5), and regulations regarding air pollution in the area where PM(2.5) is prominent. Current strategies to reduce PM(2.5) exposure include personal strategies such as avoiding high PM(2.5) areas such as highways or wearing masks outdoors, to governmental policies restricting the amount of PM(2.5) produced by organizations. This review, by highlighting the significant impact between PM(2.5) exposure and cardiovascular health will hopefully bring awareness and produce significant change regarding dealing with PM(2.5) levels worldwide.
format Online
Article
Text
id pubmed-10585625
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105856252023-10-20 PM(2.5) and cardiovascular diseases: State-of-the-Art review Krittanawong, Chayakrit Qadeer, Yusuf Kamran Hayes, Richard B. Wang, Zhen Thurston, George D. Virani, Salim Lavie, Carl J. Int J Cardiol Cardiovasc Risk Prev Review Article Air pollution, especially exposure to particulate matter 2.5 (PM(2.5)), has been associated with an increase in morbidity and mortality around the world. Specifically, it seems that PM(2.5) promotes the development of cardiovascular risk factors such as hypertension and atherosclerosis, while being associated with an increased risk of cardiovascular diseases, including myocardial infarction (MI), stroke, heart failure, and arrhythmias. In this review, we seek to elucidate the pathophysiological mechanisms by which exposure to PM(2.5) can result in adverse cardiovascular outcomes, in addition to understanding the link between exposure to PM(2.5) and cardiovascular events. It is hypothesized that PM(2.5) functions via 3 mechanisms: increased oxidative stress, activation of the inflammatory pathway of the immune system, and stimulation of the autonomic nervous system which ultimately promote endothelial dysfunction, atherosclerosis, and systemic inflammation that can thus lead to cardiovascular events. It is important to note that the various cardiovascular associations of PM(2.5) differ regarding the duration of exposure (short vs long) to PM(2.5), the source of PM(2.5), and regulations regarding air pollution in the area where PM(2.5) is prominent. Current strategies to reduce PM(2.5) exposure include personal strategies such as avoiding high PM(2.5) areas such as highways or wearing masks outdoors, to governmental policies restricting the amount of PM(2.5) produced by organizations. This review, by highlighting the significant impact between PM(2.5) exposure and cardiovascular health will hopefully bring awareness and produce significant change regarding dealing with PM(2.5) levels worldwide. Elsevier 2023-10-12 /pmc/articles/PMC10585625/ /pubmed/37869561 http://dx.doi.org/10.1016/j.ijcrp.2023.200217 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Krittanawong, Chayakrit
Qadeer, Yusuf Kamran
Hayes, Richard B.
Wang, Zhen
Thurston, George D.
Virani, Salim
Lavie, Carl J.
PM(2.5) and cardiovascular diseases: State-of-the-Art review
title PM(2.5) and cardiovascular diseases: State-of-the-Art review
title_full PM(2.5) and cardiovascular diseases: State-of-the-Art review
title_fullStr PM(2.5) and cardiovascular diseases: State-of-the-Art review
title_full_unstemmed PM(2.5) and cardiovascular diseases: State-of-the-Art review
title_short PM(2.5) and cardiovascular diseases: State-of-the-Art review
title_sort pm(2.5) and cardiovascular diseases: state-of-the-art review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585625/
https://www.ncbi.nlm.nih.gov/pubmed/37869561
http://dx.doi.org/10.1016/j.ijcrp.2023.200217
work_keys_str_mv AT krittanawongchayakrit pm25andcardiovasculardiseasesstateoftheartreview
AT qadeeryusufkamran pm25andcardiovasculardiseasesstateoftheartreview
AT hayesrichardb pm25andcardiovasculardiseasesstateoftheartreview
AT wangzhen pm25andcardiovasculardiseasesstateoftheartreview
AT thurstongeorged pm25andcardiovasculardiseasesstateoftheartreview
AT viranisalim pm25andcardiovasculardiseasesstateoftheartreview
AT laviecarlj pm25andcardiovasculardiseasesstateoftheartreview